Opportunity Information: Apply for RFA AR 28 001
The NIAMS P30 Centers Program (RFA AR 28 001) is a discretionary NIH grant opportunity designed to build and sustain integrated research centers that strengthen the scientific infrastructure needed to move discoveries faster and more efficiently from the lab toward real-world health impact. The program is run by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and is focused on creating coordinated, shared-resource environments that make high-quality research easier to conduct, more collaborative, and more reproducible. A central emphasis is improving research efficiency and accelerating scientific discovery while also improving how findings are translated into better prevention strategies, diagnostics, and treatments that ultimately improve health outcomes in NIAMS mission areas.
These P30 awards are intended to support centers working across NIAMS scientific priorities, specifically in skin biology and skin diseases, bone and muscle research including orthopaedics, and rheumatic diseases. Rather than primarily funding a single research project, a P30 center grant typically supports the underlying infrastructure that many investigators can use. In this opportunity, NIAMS is explicitly looking for centers that provide coordinated research infrastructure, shared resources, and methodological expertise that can serve multiple research teams and help drive basic, translational, and clinical research forward. The expectation is that the center will function as a hub that enables investigators to do work they could not do as effectively on their own, whether that means access to specialized technologies, advanced analytics, standardized outcome measures, or specialized consultation and design support.
A defining feature of the program is the expectation that centers will integrate state-of-the-art research resources with capabilities that strengthen clinical and translational research. This includes support for developing, testing, and disseminating novel analytical methods, improved study designs, stronger or more sensitive outcome measures, and modern data-driven approaches. The description also highlights emerging areas where centers are encouraged to build capacity and training pathways, including data science, artificial intelligence, and implementation research. In practical terms, NIAMS is signaling that it values not only cutting-edge tools and platforms, but also the expertise and workflows needed to make those tools useful across projects, and to help research findings move into clinical practice and public health settings.
Workforce development is another major goal of the program. Centers funded under this initiative are expected to foster multidisciplinary collaboration and support training and career development across career stages. That typically means creating an environment where early-career researchers, trainees, and more established investigators can work together, share methods, learn new skill sets, and participate in team science. The emphasis on multidisciplinary collaboration reflects how complex musculoskeletal, skin, and rheumatic conditions are, and how progress often requires coordinated input from clinicians, basic scientists, engineers, data scientists, biostatisticians, and implementation experts.
This opportunity uses the P30 funding instrument and is labeled "Clinical Trial Not Allowed," meaning applicants should not propose activities that meet the NIH definition of a clinical trial under this specific award. The center can still support clinical and translational research infrastructure and expertise, but the application should be structured so that the P30 itself is not conducting or directly funding an NIH-defined clinical trial as part of the center grant activities. In other words, the program supports the enabling environment, shared resources, and methods development that can benefit clinical research broadly, while keeping the P30 award itself outside the clinical trial category.
In terms of funding details provided in the source data, the opportunity lists an award ceiling of $500,000 and anticipates about 30 awards. It is administered by the National Institutes of Health, and is associated with CFDA numbers 93.313 and 93.846. The original closing date shown is 2029-03-01, indicating a long application window or multiple submission cycles depending on how NIAMS administers the announcement over time.
Eligibility is broad and includes many types of domestic U.S. organizations such as state, county, and city governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (other than small businesses) and small businesses; public housing authorities/Indian housing authorities; and federally recognized Native American tribal governments. The announcement also explicitly notes additional eligible applicant types such as Indian/Native American Tribal Governments other than federally recognized entities, eligible federal agencies, U.S. territories or possessions, faith-based or community-based organizations, and regional organizations. Notably, it also allows non-domestic (non-U.S.) entities (foreign institutions), which can be relevant for centers that rely on unique expertise, datasets, technologies, or collaborations that are international in scope, as long as the overall center structure aligns with NIAMS requirements.
Overall, this NIAMS P30 opportunity is best understood as support for high-impact, shared research infrastructure and expertise that can raise the quality and pace of research across multiple projects and teams in NIAMS mission areas. The strongest proposed centers will typically be those that can clearly show how their shared resources, methods, and collaborative structure will remove bottlenecks, improve rigor and efficiency, train the next generation of researchers in modern approaches like AI and data science, and increase the likelihood that discoveries are translated into measurable improvements in patient care and health outcomes.Apply for RFA AR 28 001
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.313, 93.846.
- This funding opportunity was created on 2026-10-09.
- Applicants must submit their applications by 2029-03-01.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- The number of recipients for this funding is limited to 30 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIAMS P30 Centers Program (RFA AR 28 001)
What is the NIAMS P30 Centers Program (RFA AR 28 001)?
The NIAMS P30 Centers Program (RFA AR 28 001) is a discretionary NIH grant opportunity that supports the creation and long-term sustainability of integrated research centers. The main purpose is to strengthen scientific infrastructure and help research discoveries move faster and more efficiently from the laboratory toward real-world health impact.
Which NIH institute runs this opportunity?
This program is administered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) within the National Institutes of Health (NIH).
What is the overall goal of a P30 center award under this program?
The goal is to build a coordinated, shared-resource research environment that improves research efficiency, supports collaboration, strengthens rigor and reproducibility, and accelerates scientific discovery and translation into better prevention strategies, diagnostics, and treatments in NIAMS mission areas.
Does this program primarily fund a single research project?
No. The opportunity emphasizes that a P30 center grant typically supports underlying infrastructure used by many investigators, rather than primarily funding one stand-alone research project.
What types of activities or resources is NIAMS looking for centers to provide?
NIAMS is looking for centers that provide coordinated research infrastructure, shared resources, and methodological expertise that multiple research teams can use. Examples described include access to specialized technologies, advanced analytics, standardized outcome measures, and specialized consultation and design support.
What scientific areas does NIAMS want these centers to cover?
The program is intended to support centers working across NIAMS scientific priorities, specifically:
- Skin biology and skin diseases
- Bone and muscle research, including orthopaedics
- Rheumatic diseases
How should the center function within the research community?
The center is expected to function as a hub that enables investigators to do work they could not do as effectively on their own. The emphasis is on shared capabilities that remove bottlenecks and make high-quality research easier to conduct and more collaborative.
What does NIAMS mean by improving research efficiency and rigor?
Based on the description, NIAMS is emphasizing coordinated shared-resource environments that support reproducible, high-quality research. This includes shared workflows, standardized measures, and methodological expertise that help multiple teams generate consistent, reliable results more efficiently.
Is clinical and translational research supported by this program?
Yes. A defining feature described is integrating state-of-the-art research resources with capabilities that strengthen clinical and translational research, including developing, testing, and disseminating improved analytical methods, study designs, and outcome measures.
Are emerging areas like data science and AI relevant to this opportunity?
Yes. The opportunity highlights emerging areas where centers are encouraged to build capacity and training pathways, including data science, artificial intelligence, and implementation research.
What is implementation research in the context of this opportunity?
The description signals interest in building capacity for implementation research as part of strengthening translation into clinical practice and public health settings. In practical terms, this aligns with supporting workflows and expertise that help research findings move into real-world use.
Does this funding opportunity allow clinical trials?
No. The opportunity is labeled "Clinical Trial Not Allowed." Applicants should not propose activities that meet the NIH definition of a clinical trial under this award.
If clinical trials are not allowed, can the center still support clinical research?
Yes. The center can support clinical and translational research infrastructure and expertise, but the application should be structured so that the P30 itself is not conducting or directly funding an NIH-defined clinical trial as part of the center grant activities.
What is the funding mechanism used for this opportunity?
This opportunity uses the P30 funding instrument, which is designed to support research center infrastructure and shared resources.
What is the award ceiling listed for this opportunity?
The source information lists an award ceiling of $500,000.
How many awards does NIAMS anticipate making?
The opportunity anticipates about 30 awards.
What CFDA numbers are associated with this grant opportunity?
The opportunity is associated with CFDA numbers 93.313 and 93.846.
What is the closing date shown for this opportunity?
The original closing date shown is 2029-03-01, suggesting a long application window or potentially multiple submission cycles depending on how NIAMS administers the announcement over time.
Who is eligible to apply for the NIAMS P30 Centers Program?
Eligibility is described as broad and includes many types of domestic U.S. organizations, including:
- State, county, and city governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Nonprofit organizations (with or without 501(c)(3) status)
- For-profit organizations (other than small businesses) and small businesses
- Public housing authorities/Indian housing authorities
- Federally recognized Native American tribal governments
Are any additional applicant types explicitly noted as eligible?
Yes. The announcement explicitly notes additional eligible applicant types, including Indian/Native American tribal governments other than federally recognized entities, eligible federal agencies, U.S. territories or possessions, faith-based or community-based organizations, and regional organizations.
Are foreign (non-U.S.) institutions eligible to apply?
Yes. The announcement allows non-domestic (non-U.S.) entities (foreign institutions). The description notes this can be relevant when a center relies on unique expertise, datasets, technologies, or international collaborations, as long as the overall center structure aligns with NIAMS requirements.
What kinds of collaboration does NIAMS expect from funded centers?
The opportunity emphasizes multidisciplinary collaboration and team science. It highlights the need for coordinated input from groups such as clinicians, basic scientists, engineers, data scientists, biostatisticians, and implementation experts to address complex musculoskeletal, skin, and rheumatic conditions.
Is workforce development part of the program expectations?
Yes. Workforce development is described as a major goal. Centers are expected to foster multidisciplinary collaboration and support training and career development across career stages.
Who benefits from the infrastructure supported by a P30 center?
The infrastructure is intended to serve multiple investigators and research teams. The value proposition described is shared access to resources and expertise that make it easier to conduct high-quality basic, translational, and clinical research.
What are examples of the "shared resources" a center might provide (based on the description)?
Examples mentioned include specialized technologies, advanced analytics, standardized outcome measures, and specialized consultation and design support, as well as capabilities for novel analytical methods, improved study designs, and data-driven approaches.
What makes a proposed center competitive under this opportunity (based on the description)?
The description suggests stronger centers will clearly explain how their shared resources, methods, and collaborative structure will remove bottlenecks, improve rigor and efficiency, train researchers in modern approaches like AI and data science, and increase the likelihood that discoveries translate into measurable improvements in patient care and health outcomes.
What kinds of health impacts is NIAMS aiming for through this program?
NIAMS emphasizes translation into improved prevention strategies, diagnostics, and treatments that ultimately improve health outcomes in NIAMS mission areas.
Browse more opportunities from the same category: Health
Previous opportunity: BJS FY 2026 Invited to Apply - Federal Justice Statistics Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AR 28 001
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AR 28 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed) Apply for RFA RM 27 016 Funding Number: RFA RM 27 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 27 007 Funding Number: RFA RM 27 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed) Apply for RFA HG 27 010 Funding Number: RFA HG 27 010 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed) Apply for RFA HG 27 009 Funding Number: RFA HG 27 009 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed) Apply for RFA MH 27 125 Funding Number: RFA MH 27 125 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed) Apply for RFA HL 27 010 Funding Number: RFA HL 27 010 Agency: National Institutes of Health Category: Health Funding Amount: $6,444,000 |
| Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required) Apply for PAR 28 091 Funding Number: PAR 28 091 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) Apply for RFA DA 28 011 Funding Number: RFA DA 28 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) Apply for RFA DA 28 012 Funding Number: RFA DA 28 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) Apply for RFA NS 28 010 Funding Number: RFA NS 28 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required) Apply for PAR 28 022 Funding Number: PAR 28 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed) Apply for RFA DA 28 013 Funding Number: RFA DA 28 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) Apply for RFA DK 27 122 Funding Number: RFA DK 27 122 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) Apply for PAR 27 090 Funding Number: PAR 27 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) Apply for PAR 28 090 Funding Number: PAR 28 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) Apply for RFA AI 27 018 Funding Number: RFA AI 27 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) Apply for RFA CA 28 013 Funding Number: RFA CA 28 013 Agency: National Institutes of Health Category: Health Funding Amount: $700,000 |
| Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed) Apply for RFA AI 28 031 Funding Number: RFA AI 28 031 Agency: National Institutes of Health Category: Health Funding Amount: $3,500,000 |
| Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed) Apply for RFA CA 28 004 Funding Number: RFA CA 28 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 28 001 Funding Number: RFA AA 28 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AR 28 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.